Compare GNSS & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNSS | SEER |
|---|---|---|
| Founded | 1992 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.1M | 97.3M |
| IPO Year | 1996 | 2020 |
| Metric | GNSS | SEER |
|---|---|---|
| Price | $1.86 | $1.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.75 | N/A |
| AVG Volume (30 Days) | 168.3K | ★ 214.1K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 44.44 | 9.40 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $26,306,790.00 | $16,578,000.00 |
| Revenue This Year | $80.08 | $2.14 |
| Revenue Next Year | N/A | $25.90 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 29.50 | 16.99 |
| 52 Week Low | $1.40 | $1.65 |
| 52 Week High | $2.70 | $2.41 |
| Indicator | GNSS | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 42.37 | 44.32 |
| Support Level | $1.77 | $1.76 |
| Resistance Level | $1.93 | $1.96 |
| Average True Range (ATR) | 0.10 | 0.06 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 14.10 | 46.15 |
Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.